BRIEF published on 09/17/2024 at 15:05, 1 year 10 months ago Applied DNA Secures Significant Follow-on Order from IVD Manufacturer Cancer Diagnostics Linea DNA PCR Technology Applied DNA IVD
BRIEF published on 09/17/2024 at 15:05, 1 year 10 months ago Applied DNA obtient une importante commande complémentaire d'un fabricant de dispositifs de diagnostic in vitro Technologie PCR ADN Appliqué Diagnostic Du Cancer DIV Ligne ADN
BRIEF published on 09/17/2024 at 14:47, 1 year 10 months ago Franchissements de seuils chez Groupe Partouche Droits De Vote Franchissements De Seuils Groupe Partouche Patrick Partouche Ispar Holding
BRIEF published on 09/17/2024 at 14:47, 1 year 10 months ago Threshold crossings at Groupe Partouche Voting Rights Threshold Crossings Partouche Group Patrick Partouche Ispar Holding
BRIEF published on 09/17/2024 at 14:45, 1 year 10 months ago Goldman Sachs vend ses actions GENSIGHT BIOLOGICS S.A. Euronext Paris Franchissement De Seuils Goldman Sachs Cession D'actions GenSight Biologics
BRIEF published on 09/17/2024 at 14:45, 1 year 10 months ago Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares Euronext Paris Goldman Sachs Crossing Thresholds Transfer Of Shares GenSight Biologics
BRIEF published on 09/17/2024 at 14:35, 1 year 10 months ago Trans Canada Gold Corp. Places Second Multilateral Heavy Oil Well on Production Near Lloydminster, Alberta Oil Production Multilateral Well Lloydminster Trans Canada Gold GP Reservoir
BRIEF published on 09/17/2024 at 14:35, 1 year 10 months ago Trans Canada Gold Corp. met en production un deuxième puits multilatéral de pétrole lourd près de Lloydminster, en Alberta Production De Pétrole Puits Multilatéral Lloydminster L'or Transcanadien Réservoir GP
BRIEF published on 09/17/2024 at 14:35, 1 year 10 months ago Ripple Therapeutics Announces Collaboration with AbbVie for Glaucoma Therapy Development Partnership Drug Delivery Ophthalmology Glaucoma Therapy Biodegradable Implants
BRIEF published on 09/17/2024 at 14:35, 1 year 10 months ago Ripple Therapeutics annonce une collaboration avec AbbVie pour le développement d'un traitement contre le glaucome Partenariat Ophtalmologie Traitement Du Glaucome Administration De Médicaments Implants Biodégradables
Published on 07/23/2026 at 14:30, 1 hour 55 minutes ago Klondike Gold Reports Increased Montana Creek Royalty Gold Receipts, Completes Phase 1 2026 Drill Program and Provides Exploration Update
Published on 07/23/2026 at 14:00, 2 hours 25 minutes ago GameSquare Repurchases Over 1 Million Shares in July 2026
Published on 07/23/2026 at 14:00, 2 hours 25 minutes ago CCL to Hold Live Webcast Call to Discuss 2026 Second Quarter Results, Thursday, August 13, 2026, at 7:30 a.m. ET
Published on 07/23/2026 at 13:30, 2 hours 55 minutes ago AirIQ Announces March 31, 2026 Year End Results Reports Record 23% Growth in Recurring Revenue
Published on 07/23/2026 at 13:05, 3 hours 20 minutes ago Aton Announces CAD$4 Million Private Placement
Published on 07/23/2026 at 16:08, 17 minutes ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 07/23/2026 at 16:07, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 07/22/2026 at 18:19, 22 hours 6 minutes ago Covivio place avec succès 500 M€ d’obligations vertes à 7 ans
Published on 07/22/2026 at 18:19, 22 hours 6 minutes ago Covivio successfully places €500 million of 7-year European Green Bonds
Published on 07/22/2026 at 17:45, 22 hours 40 minutes ago Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:45, 22 hours 40 minutes ago Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Published on 07/22/2026 at 17:40, 22 hours 45 minutes ago Report on share repurchases from 15 to 21 July 2026
